アーカンソー州における転移性癌の臨床試験
アーカンソー州内の拠点で、転移性癌に関する14件の研究が参加者を募集しています。
アーカンソー州内の都市
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- University of Arkansas Medical School, Little Rock
被験者募集中第1相
19歳以上 · 全性別 · 2026/10/01更新 · NCT06586957Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Highlands Oncology Group, Fayetteville
- Highlands Oncology Group, Rogers
- Highlands Oncology Group, Springdale
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Highlands Oncology Group, Fayetteville
- Highlands Oncology Group, Rogers
- Highlands Oncology Group, Springdale
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07222566A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Central Arkansas Radiation Therapy Institute, dba CARTI, Bryant
- Central Arkansas Radiation Therapy Institute, dba CARTI, Conway
- CARTI Cancer Center, Little Rock
- 他2件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Springdale
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06103864A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- University of Arkansas for Medical Sciences, Little Rock
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Genesis Cancer and Blood Institute, Hot Springs
- Highlands Oncology Group, Springdale
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Highlands Oncology Group, Fayetteville
- Highlands Oncology Group, Rogers
- Highlands Oncology Group, PA, Springdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07227415A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Highlands Oncology Group, Springdale
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- University of Arkansas - Winthrop P. Rockefeller Cancer Institute, Little Rock
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Genesis Cancer and Blood Institute, Hot Springs
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/05/08更新 · NCT06697301Collection and Storage of Tissue and Blood Samples From Patients With Cancer
- Mercy Hospital Fort Smith, Fort Smith
被験者募集中観察研究
2 Months · 全性別 · 2026/03/05更新 · NCT02474160SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Little Rock
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。